Estrigenix secures investment from CU Ventures
CU Ventures invests with Estrigenix to further development of our drug lead as a safe alternative to traditional hormone replacement therapy
Uncategorized
Dan Sem honored with Wisconsin Inno 2021 Fire Award
VP for Business Development, Dan Sem, was honored with a 2021 Fire Award from Wisconsin Inno for his work with non-profit “Bridges to Cures”
Estrigenix featured in MKE Startup News
CSO Karyn Frick interviewed by MKE Startup News
Estrigenix presents at 2021 Early Stage Symposium
Estrigenix presents on EGX358 at the Wisconsin Early Stage Symposium, Nov. 3rd
CEO Donaldson receives award for Excellence in Research
William Donaldson received Marquette University’s highest honor for research and scholarship at the annual Distinguished Scholars event
Estrigenix runner-up in Wisconsin Governor’s Business Plan Competition
Estrigenix Therapeutics awarded runner-up in Life Sciences category at 2021 Wisconsin Governor’s Business Plan contest
Estrigenix receives funding from UWM Research Foundation
Estrigenix Therapeutics, a spin-out of research from UWM, receives funding for business development
CSO Karyn Frick presents at Women’s Health Division of Yale Medical School Department of Psychiatry
Dr. Frick discussed her research at a virtual Grand Rounds presentation of Yale Medical School
Estrigenix founders present at Tech Council Innovation Network
Hear from a promising drug company that was founded by medical researchers from three Milwaukee-area universities at the Thursday, May 9 luncheon meeting of the Tech Council Innovation Network in Wauwatosa.
Milwaukee-area professors closer to preventing dementia in women
Three Milwaukee-area professors from three universities are working together to prevent dementia in women.